Showing results (271-280 of 357) with videos related to

Sort By:
Pageof 36
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2015
Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic LeukemiaPiyanuch Kongtim, Uday Popat, Antonio Jimenez, et al.
Blood Advances|May 9, 2022
High-sensitivity next-generation sequencing MRD assessment in ALL identifies patients at very low risk of relapseNicholas J Short, Hagop Kantarjian, Farhad Ravandi, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 17, 2026
Treatment in Clinical Trials Could Mitigate Socioeconomic and Racial Disparities in Acute Myeloid LeukemiaMahesh Swaminathan, Hussein A Abbas, Michael Roth, et al.
Transplantation and Cellular Therapy|March 25, 2022
Impact of Induction With VCD Versus VRD on the Outcome of Patients With Multiple Myeloma After an Autologous Hematopoietic Stem Cell TransplantationAimaz Afrough, Oren Pasvolsky, Junsheng Ma, et al.
British Journal of Haematology|September 7, 2022
Positron emission tomography derived metrics in relapsed or refractory large B-cell lymphoma with residual disease before autologous stem cell transplantHua-Jay J Cherng, Guofan Xu, Lei Feng, et al.
The New England Journal of Medicine|February 6, 2020
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid TumorsEnli Liu, David Marin, Pinaki Banerjee, et al.
Blood Cancer Journal|January 10, 2024
Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experienceOren Pasvolsky, Sassine Ghanem, Denái R Milton, et al.
Blood Advances|May 13, 2020
Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantationMonzr M Al Malki, Dongyun Yang, Myriam Labopin, et al.
American Journal of Hematology|October 10, 2019
Haploidentical transplantation for acute myeloid leukemia patients with minimal/measurable residual disease at transplantationSamer A Srour, Rima M Saliba, Maria C B Bittencourt, et al.
Blood Advances|September 13, 2018
Is a matched unrelated donor search needed for all allogeneic transplant candidates?Stefan O Ciurea, Maria Cecilia Borges Bittencourt, Denái R Milton, et al.
Pageof 36